The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System.
Συγγραφείς: Güder S; Department of Dermatology, Bezmialem Vakıf University, Istanbul, Turkey., Küçük ÖS; Department of Dermatology, Bezmialem Vakıf University, Istanbul, Turkey., Dizman D; Department of Dermatology, Bezmialem Vakıf University, Istanbul, Turkey., Temiz SNY; Department of Dermatology, Maltepe University, Istanbul, Turkey., Gencebay G; Department of Dermatology, Bezmialem Vakıf University, Istanbul, Turkey., Özay M; Department of Dermatology, Bezmialem Vakıf University, Istanbul, Turkey., Güder H; Department of Dermatology, Maltepe University, Istanbul, Turkey.
Πηγή: International journal of dermatology [Int J Dermatol] 2026 Sep; Vol. 65 (9), pp. 1856-1863. Date of Electronic Publication: 2026 Mar 01.
Τύπος έκδοσης: Journal Article; Validation Study
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE
Imprint Name(s): Publication: Oxford : Blackwell Science
Original Publication: Philadelphia, Lippincott.
Ιατρικοί όροι (MeSH): Scabies*/drug therapy , Scabies*/diagnosis , Scabies*/parasitology , Adrenal Cortex Hormones*/therapeutic use , Glucocorticoids*/therapeutic use , Severity of Illness Index*, Pruritus/drug therapy ; Pruritus/parasitology ; Humans ; Female ; Adult ; Cross-Sectional Studies ; Male ; Middle Aged ; Animals ; Young Adult ; Adolescent ; Reproducibility of Results ; Dermoscopy
Περίληψη: Background: Corticosteroids are frequently used to relieve pruritus or eczematization in scabies, but empirical or prolonged use before diagnosis may modify the disease course.
Objectives: This study aimed to examine the impact of corticosteroid exposure (misdiagnosis-related or adjunctive) on clinical severity, mite burden, and healing time, and to assess the initial measurement properties of a novel composite scoring system for standardized severity assessment.
Methods: In this cross-sectional analytical study, 180 adults (18-50 years) with dermoscopically confirmed scabies were classified into three groups: misdiagnosed (steroid-only), standard therapy + steroid, and standard therapy. Severity was assessed using a 0-9 composite score integrating pruritus (NRS), mite index, and body surface area involvement (BSA). Internal consistency (Cronbach's α) and inter-rater reliability (ICC) were evaluated.
Results: Both steroid-exposed groups showed significantly higher severity scores (all p < 0.001), longer disease duration (median 8 weeks vs. 3 weeks), and delayed healing compared with standard therapy. Steroid duration correlated with mite index, BSA, and total score (all p ≤ 0.005). The scale showed borderline-to-acceptable internal consistency; ICC was good for NRS (0.79) and fair-to-moderate for the total score (0.45).
Conclusion: Prior or concurrent corticosteroid exposure increases disease severity and delays recovery in scabies, likely by suppressing local immune responses. The proposed Scabies Severity Scale is a practical, preliminary tool for standardized severity assessment, pending external validation.
(© 2026 the International Society of Dermatology.)
References: Int J Mol Sci. 2021 Nov 16;22(22):. (PMID: 34830245)
Biomed Res Int. 2018 Apr 11;2018:9625936. (PMID: 29850592)
Clin Exp Dermatol. 2025 Jun 25;50(7):1446-1447. (PMID: 40036832)
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2387. (PMID: 24069468)
Korean J Parasitol. 2020 Dec;58(6):669-674. (PMID: 33412771)
Parasit Vectors. 2017 Aug 10;10(1):385. (PMID: 28797273)
Clin Microbiol Rev. 2007 Apr;20(2):268-79. (PMID: 17428886)
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):126-132. (PMID: 34592030)
J Am Acad Dermatol. 2006 Jan;54(1):1-15; quiz 16-8. (PMID: 16384751)
Parasite Immunol. 2022 Jan;44(1-2):e12900. (PMID: 34923637)
Pharmacol Ther. 2002 Oct;96(1):23-43. (PMID: 12441176)
J Allergy Clin Immunol. 2018 Nov;142(5):1375-1390. (PMID: 30409247)
J Am Acad Dermatol. 2015 Mar;72(3):541-549.e2. (PMID: 25592622)
Dermatol Pract Concept. 2025 Oct 01;15(4):. (PMID: 41236262)
Int J Dermatol. 2024 Dec;63(12):1642-1656. (PMID: 38922701)
An Bras Dermatol. 2025 May-Jun;100(3):487-519. (PMID: 40320333)
Exp Dermatol. 2008 Dec;17(12):1063-72. (PMID: 19043850)
Parasit Vectors. 2017 Jun 20;10(1):297. (PMID: 28633664)
Contributed Indexing: Keywords: corticosteroid exposure; dermoscopy; disease severity; mite index; scabies; scabies severity scale; steroid‐modified scabies
Substance Nomenclature: 0 (Adrenal Cortex Hormones)
0 (Glucocorticoids)
Entry Date(s): Date Created: 20260301 Date Completed: 20260804 Latest Revision: 20260813
Update Code: 20260813
PubMed Central ID: PMC13436245
DOI: 10.1111/ijd.70326
PMID: 41765874
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1365-4632
DOI:10.1111/ijd.70326